|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation related to options granted to employees and directors | |||||
| Change in operating lease liability, net | |||||
| Decrease (increase) in prepaid expenses and other accounts receivable | |||||
| Increase (decrease) in trade payables | |||||
| Increase in accrued expense | |||||
| Gain on change in fair value of warrants (Note 7) | |||||
| Increase (decrease) in employees related liability and accrued expenses | |||||
| Total net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Changes in short-term deposit | |||||
| Total net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of shares in at-the-market (ATM) offering (Note 8) | |||||
| Proceeds from Issuance of shares for private placement (Note 8) | |||||
| Proceeds from short-term loans (Note 11) | |||||
| Proceeds from warrants issuance (Note 7) | |||||
| Debt-for-Equity Swap | |||||
| Total net cash provided by financing activities | |||||
| Decrease in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at the beginning of the period | |||||
| Cash, cash equivalents and restricted cash at end of the period | |||||
| Non-Cash Activities: | |||||
| ROU asset decreased, resulted from lease modification (Note 4) | |||||
| Lease liability decreased, resulted from lease modification (Note 4) | |||||
| Finance expenses resulted from lease modification (Note 5) | |||||
| Reclassifying the warrants liabilities to equity (Note 8) | |||||
Loading...
